Premarket Mover: NRX Pharmaceuticals Inc (NRXP) Down 3.67%

NRX Pharmaceuticals Inc (NRXP) is down Friday morning, with the stock decreasing -3.67% in pre-market trading to 1.05. NRXP's short-term technical score of 58 indicates that the stock has traded more bullishly over the last month than 58% of stocks on the market. In the Biotechnology industry, which ranks 116 out of 146 industries, NRXP ranks higher than 67% of stocks. NRX Pharmaceuticals Inc has risen 37.97% over the past month, closing at $0.81 on October 28. During this period of time, the stock fell as low as $0.81 and as high as $1.34. NRXP has an average analyst recommendation of Strong Buy. The company has an average price target of $3.00.

NRXP has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on NRXP!

See Full NRXP Report

NRX Pharmaceuticals Inc has a Long-Term Technical rank of 86. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 14% of the market scoring higher. In the Biotechnology industry which is number 127 by this metric, NRXP ranks better than 127% of stocks.

Important Dates for Investors in NRXP:

-NRX Pharmaceuticals Inc is set to release earnings on 2/12/2023. Over the last 12 months, the company has reported EPS of $-2.09. -We do not have a set dividend date for NRX Pharmaceuticals Inc at this time. Click Here To Get The Full Report on NRX Pharmaceuticals Inc (NRXP)